# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000320017-15-000064
Filing Date
2015-08-06
Accepted
2015-08-06 16:07:06
Documents
41
Period of Report
2015-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | a8-kprandpptq22015.htm | 8-K | 27190
2 | EXHIBIT 99.1 | exhibt991prq22015.htm | EX-99.1 | 43107
3 | EXHIBIT 99.2 | caladriuscorporatepresen.htm | EX-99.2 | 33274
4 |  | caladriuscorporatepresen001.jpg | GRAPHIC | 110735
5 |  | caladriuscorporatepresen002.jpg | GRAPHIC | 210087
6 |  | caladriuscorporatepresen003.jpg | GRAPHIC | 62708
7 |  | caladriuscorporatepresen004.jpg | GRAPHIC | 133867
8 |  | caladriuscorporatepresen005.jpg | GRAPHIC | 165882
9 |  | caladriuscorporatepresen006.jpg | GRAPHIC | 98418
10 |  | caladriuscorporatepresen007.jpg | GRAPHIC | 183365
11 |  | caladriuscorporatepresen008.jpg | GRAPHIC | 131539
12 |  | caladriuscorporatepresen009.jpg | GRAPHIC | 189800
13 |  | caladriuscorporatepresen010.jpg | GRAPHIC | 120091
14 |  | caladriuscorporatepresen011.jpg | GRAPHIC | 105932
15 |  | caladriuscorporatepresen012.jpg | GRAPHIC | 142330
16 |  | caladriuscorporatepresen013.jpg | GRAPHIC | 105784
17 |  | caladriuscorporatepresen014.jpg | GRAPHIC | 120201
18 |  | caladriuscorporatepresen015.jpg | GRAPHIC | 134443
19 |  | caladriuscorporatepresen016.jpg | GRAPHIC | 180909
20 |  | caladriuscorporatepresen017.jpg | GRAPHIC | 91070
21 |  | caladriuscorporatepresen018.jpg | GRAPHIC | 144611
22 |  | caladriuscorporatepresen019.jpg | GRAPHIC | 123870
23 |  | caladriuscorporatepresen020.jpg | GRAPHIC | 72400
24 |  | caladriuscorporatepresen021.jpg | GRAPHIC | 154088
25 |  | caladriuscorporatepresen022.jpg | GRAPHIC | 172022
26 |  | caladriuscorporatepresen023.jpg | GRAPHIC | 168390
27 |  | caladriuscorporatepresen024.jpg | GRAPHIC | 154080
28 |  | caladriuscorporatepresen025.jpg | GRAPHIC | 124669
29 |  | caladriuscorporatepresen026.jpg | GRAPHIC | 183055
30 |  | caladriuscorporatepresen027.jpg | GRAPHIC | 132538
31 |  | caladriuscorporatepresen028.jpg | GRAPHIC | 118982
32 |  | caladriuscorporatepresen029.jpg | GRAPHIC | 67052
33 |  | caladriuscorporatepresen030.jpg | GRAPHIC | 138187
34 |  | caladriuscorporatepresen031.jpg | GRAPHIC | 143658
35 |  | caladriuscorporatepresen032.jpg | GRAPHIC | 153129
36 |  | caladriuscorporatepresen033.jpg | GRAPHIC | 110992
37 |  | caladriuscorporatepresen034.jpg | GRAPHIC | 153165
38 |  | caladriuscorporatepresen035.jpg | GRAPHIC | 84635
39 |  | caladriuscorporatepresen036.jpg | GRAPHIC | 144120
40 |  | caladriuscorporatepresen037.jpg | GRAPHIC | 121127
41 |  | caladriuscorporatepresen038.jpg | GRAPHIC | 106590
| Complete submission text file | 0000320017-15-000064.txt |  | 7077105

Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 151033156
SIC: 8090 Services-Misc Health & Allied Services, NEC